WHO and Eli Lilly Warn of Dangerous Fake Weight-Loss Drugs

Counterfeit versions of popular medications Ozempic, Mounjaro, and others pose serious health risks.

WHO issues global alert on falsified semaglutide batches found in multiple countries.
Eli Lilly files lawsuits against entities selling counterfeit tirzepatide products.
Fake drugs contain incorrect dosages or harmful substances like insulin and bacteria.
Patients advised to only buy medications from licensed and verified sources.
High demand and shortages of GLP-1 drugs fuel the rise of dangerous counterfeit markets.